Dave saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 94 to 96.
Looking For The Best Stocks To Buy And Watch? Start Here
The revised score means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength.
Dave is now out of buy range after clearing the 125.00 buy point in a cup without handle.
The stock earns an 83 EPS Rating, meaning its recent quarterly and longer-term annual earnings growth is outpacing 83% of all stocks.
Its Accumulation/Distribution Rating of D- shows moderate selling by institutional investors over the last 13 weeks. Look for the rating to improve to at least a C or better.
In Q2, the company reported 211% earnings-per-share growth. Top line growth increased 64%, up from 47% in the prior report. That marks two consecutive reports with rising growth.
Dave earns the No. 4 rank among its peers in the Computer-Technical Services industry group. IBEX is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
